ReWalk Robotics Hopes to Raise $50M in IPO
From Boston Herald:
A company with U.S. headquarters in Marlborough that was recently awarded FDA approval to sell its robotic exoskeletons for paraplegics plans to raise $50 million in an IPO this week, possibly on Friday.
Israeli-based ReWalk Robotics is planning to sell 3.5 million shares for between $14 and $16 each, which puts it at the low end of the 13 local health care companies which have gone public since the beginning of the year, more than any other year in history. Most of those have been biotech companies, however, making ReWalk the first robotics-focused company to do so in at least a couple of years... (cont'd)
Comments (0)
This post does not have any comments. Be the first to leave a comment below.
Featured Product
OnLogic's Helix 520 Series of Scalable Fanless Computers
The Helix 520 series utilizes the latest Intel Core Ultra processors with integrated edge AI capabilities to deliver exceptional performance and industrial-grade reliability for demanding applications in automation, robotics, machine vision, and more. Its unique modular design allows for flexible scaling of CPU and GPU performance, while robust connectivity and expansion options ensure seamless integration.
